

Celularity (CELU) stock surged 131% following a $300M U.S. manufacturing collaboration with MuseCell Innovations in New Jersey.
You can purchase shares of Celularity (NASDAQ:CELU) through any online brokerage.
Other companies in Celularity’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Celularity has a consensus price target of $6.00.
The stock price for Celularity (NASDAQ: CELU) is $1.0612 last updated October 23, 2026 at 8:55 AM EDT.
There are no upcoming dividends for Celularity.
Celularity does not have any upcoming earnings scheduled.
There is no upcoming split for Celularity.
Celularity is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Celularity Inc is a regenerative and cellular medicine company focused on developing placental-derived allogeneic cell therapies and biomaterial products for the treatment of degenerative diseases, aging-related conditions, cancer, and immune...